期刊文献+

抗生素载体系统克服耐药细菌的研究进展 被引量:3

Progress in studies of antibiotic delivery systems to overcome bacterial resistance
原文传递
导出
摘要 近年来,耐药菌感染率居高不下。细菌主要通过减少药物摄取和增加外排、改变靶位、钝化或酶解药物等机制,对各种抗生素产生耐药。本文综述国内外通过载体系统克服耐药的新技术,如脂质体、纳米粒、无机金属载体等。脂质体和纳米粒由于生物相容性和降解性较好,且能靶向网状内皮系统,应用较多。本文主要是介绍近十年来,国外载体系统在抗生素抗耐药菌方面的研究情况,这些载体能克服部分耐药机制,如改变细菌细胞膜,而增加药物在感染部位的浓度,并且减少毒副作用。 In recent years, drug-resistant bacteria and the incidence of intracellular infection were increasing. Antibiotic resistance is the phenomenon that bacteria exhibit significantly reduced susceptibility to antimierobials by mechanisms such as altered drug uptake and increase efflux, altered drug target and drug inactivation. The current technologies for increasing the bioavailability by novel delivery systems to overcome resistance of antibiotics were reviewed, such as liposomes, nanoparticles and inorganic metal carrier. Liposomes and nanoparticles have good biocompatibility and degradation ability and can target the reticuloendothelial system, so they are widely used. The purpose of this review is to provide background information in antibiotic delivery systems gathered from papers published over the last ten years. It seems clear that such drug carriers can increase drug concentration at infected sites and reduce drug toxicity by overcome some resistance mechanisms, such as changing the bacterial cell membranes.
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第18期2168-2172,共5页 Chinese Journal of New Drugs
基金 江苏省高校自然科学基金(10KJB350002)
关键词 耐药菌 胞内感染 脂质体 纳米粒 金属载体 drug-resistant bacteria intracellular infection liposome nanoparticle metal carrier
  • 相关文献

参考文献26

  • 1KUMARASAMY KK, TOLEMAN MA, WALSH TR, et aL E- mergence of a new antibiotic resistance mechanism in India, Pa- kistan, and the UK : a molecular, biological, and epidemiological study[J]. Lancet Infect Dis, 2010, 10(9) : 597 -602.
  • 2BLACK MT, HODGSON J. Novel target sites in bacteria for o- vercoming antibiotic resistance[ J]. Adv Drug Deliv Rev, 2005, 57(10) :1528 -1538.
  • 3DHOPLE V, KRUKEMEYER A, RAMAMOORTHY A. The hu- man beta-defensin-3, an antibacterial pepticle with multiple bio- logical functions[ J]. Biochim Biophys Acta, 2006, 1758 (9) : 1499 - 1512.
  • 4WRIGHT GD. Bacterial resistance to antibiotic: enzymatic deg- radation and modification [ J ]. Adv Drug Dellv Re , 2005, 57 (10) : 1451 - 1470.
  • 5KUMAR A, SCHWEIZER HP. Bacterial resistance to antibiot- ics: active efflux and reduced uptake [ J]. Adv Drug Deliv Rev, 2005, 57(10) : 1486 -1513.
  • 6DONADIO S, CARRANO L, BRANDI L, et al. Targets and as- says for discovering novel antibacterial agents [ J ]. J Biotechnol, 2002, 99(3) : 175 -185.
  • 7MAH TF, O'TOOLE GA. Mechanisms of biofilm resistance to an- timicrobial agents[ J]. Trends Microbiol, 200l, 9 (1): 34- 39.
  • 8PINTO-ALPHANDARY kl, ANDREMONT A, COUVREUIR P, et al. Targeted delivery of antibiotics using liposomes and nanop- articles : research and applications [ J ]. lnt J Antimicrob Agents, 2000, 13(3): 155-168.
  • 9CARRYN S, CHANTEUX H, SARAL C, et al. Intraeellular pharmaeodynamics of antibiotics[ J ]. Infect Dis Clin North Am, 2003, 17(3) : 615 -634.
  • 10VAN BAMBEKE F, BABCIA-MACAY M, LEMAIRE S, et al. Cellular pharmacodynamies and pharmacokineties of antibiotics: current views and perspectives[ J]. Curt Opin Drug Discov Devel, 2006, 9(2): 218-230.

二级参考文献28

共引文献6

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部